Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-58.95%
2024-111.98%
2023-21.52%
202234.80%
2021-0.42%
2020-85.50%
201955.84%
2018-17.69%
201716.71%
201612.49%